Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 4
2004 2
2006 3
2007 4
2008 9
2009 9
2010 10
2011 5
2012 8
2013 7
2014 10
2015 6
2016 7
2017 11
2018 19
2019 24
2020 20
2021 19
2022 18
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden.
Levin J, Baiardi S, Quadalti C, Rossi M, Mammana A, Vöglein J, Bernhardt A, Perrin RJ, Jucker M, Preische O, Hofmann A, Höglinger GU, Cairns NJ, Franklin EE, Chrem P, Cruchaga C, Berman SB, Chhatwal JP, Daniels A, Day GS, Ryan NS, Goate AM, Gordon BA, Huey ED, Ibanez L, Karch CM, Lee JH, Llibre-Guerra J, Lopera F, Masters CL, Morris JC, Noble JM, Renton AE, Roh JH, Frosch MP, Keene CD, McLean C, Sanchez-Valle R, Schofield PR, Supnet-Bell C, Xiong C, Giese A, Hansson O, Bateman RJ, McDade E; Dominantly Inherited Alzheimer Network; Parchi P. Levin J, et al. Among authors: parchi p. Alzheimers Dement. 2024 Apr 26. doi: 10.1002/alz.13818. Online ahead of print. Alzheimers Dement. 2024. PMID: 38666355
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification.
Mammana A, Baiardi S, Rossi M, Quadalti C, Ticca A, Magliocchetti F, Bernhardt A, Capellari S, Parchi P. Mammana A, et al. Among authors: parchi p. Clin Chem Lab Med. 2024 Mar 11. doi: 10.1515/cclm-2023-1472. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 38456740 Free article.
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C, Roeben B, Mammana A, Zimmermann M, Hauser AK, Deuschle C, Schulte C, Liepelt-Scarfone I, Gasser T, Parchi P. Brockmann K, et al. Among authors: parchi p. NPJ Parkinsons Dis. 2024 Jan 20;10(1):24. doi: 10.1038/s41531-023-00627-5. NPJ Parkinsons Dis. 2024. PMID: 38242875 Free PMC article.
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F, Mastrangelo A, Poleggi A, Ladogana A, Capellari S, Parchi P. Bentivenga GM, et al. Among authors: parchi p. Acta Neuropathol. 2024 Jan 19;147(1):18. doi: 10.1007/s00401-023-02663-0. Acta Neuropathol. 2024. PMID: 38240849 Free PMC article.
Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.
Gonzalez-Ortiz F, Karikari TK, Bentivenga GM, Baiardi S, Mammana A, Turton M, Kac PR, Mastrangelo A, Harrison P, Capellari S, Zetterberg H, Blennow K, Parchi P. Gonzalez-Ortiz F, et al. Among authors: parchi p. Alzheimers Dement. 2024 Jan;20(1):745-751. doi: 10.1002/alz.13516. Epub 2023 Oct 19. Alzheimers Dement. 2024. PMID: 37858957 Free PMC article.
199 results